These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 15696452)

  • 61. Adherence to K/DOQI guidelines for calcium-based phosphate binders in clinical practice.
    Shastri J; Tran A; Covit A; Pepe J; Sherman RA
    J Ren Nutr; 2008 Jul; 18(4):370-4. PubMed ID: 18558302
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Dialysis facility ownership and epoetin dosing in patients receiving hemodialysis.
    Thamer M; Zhang Y; Kaufman J; Cotter D; Dong F; Hernán MA
    JAMA; 2007 Apr; 297(15):1667-74. PubMed ID: 17440144
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Relationships between hemoglobin and hematocrit levels and hospitalization and survival rates in dialysis patients.
    Brattich M
    Nephrol Nurs J; 2003 Apr; 30(2):231-4. PubMed ID: 12737001
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Revisiting the hemodialysis dose.
    Leypoldt JK; Cheung AK
    Semin Dial; 2006; 19(2):96-101. PubMed ID: 16551284
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [DOPPS estimate of patient life years attributable to modifiable hemodialysis practices in Spain].
    Piera L; Cruz JM; Braga-Gresham JL; Eichleay MA; Pisoni RL; Port FK
    Nefrologia; 2007; 27(4):496-504. PubMed ID: 17944588
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Trends in anemia treatment with erythropoietin usage and patient outcomes.
    Collins AJ; Ma JZ; Xia A; Ebben J
    Am J Kidney Dis; 1998 Dec; 32(6 Suppl 4):S133-41. PubMed ID: 9892380
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Correlates affecting survival in chronic hemodialysis patients: the combined impact of albumin and high hemoglobin levels on improving outcomes, local and national results.
    Capelli JP; Kushner H
    Hemodial Int; 2008 Oct; 12(4):450-62. PubMed ID: 19090868
    [TBL] [Abstract][Full Text] [Related]  

  • 68. K/DOQI guidelines for bone metabolism and disease in chronic kidney disease patients: some therapeutic implications.
    Uribarri J;
    Semin Dial; 2004; 17(5):349-50. PubMed ID: 15461740
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Comparative mortality of hemodialysis patients at for-profit and not-for-profit dialysis facilities in the United States, 1998 to 2003: a retrospective analysis.
    Foley RN; Fan Q; Liu J; Gilbertson DT; Weinhandl ED; Chen SC; Collins AJ
    BMC Nephrol; 2008 Jun; 9():6. PubMed ID: 18582384
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Changing hemodialysis thresholds for optimal survival.
    Szczech LA; Lowrie EG; Li Z; Lew NL; Lazarus JM; Owen WF
    Kidney Int; 2001 Feb; 59(2):738-45. PubMed ID: 11168957
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Adherence to mineral and bone disorder clinical practice guidelines in chronic kidney disease.
    Panawong W; Chaiyakum A; Pongskul C
    J Med Assoc Thai; 2011 Oct; 94(10):1175-83. PubMed ID: 22145501
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Kidney Disease Outcomes Quality Initiative (K/DOQI) and the Dialysis Outcomes and Practice Patterns Study (DOPPS): nutrition guidelines, indicators, and practices.
    Combe C; McCullough KP; Asano Y; Ginsberg N; Maroni BJ; Pifer TB
    Am J Kidney Dis; 2004 Nov; 44(5 Suppl 2):39-46. PubMed ID: 15486873
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Longitudinal Associations among Renal Urea Clearance-Corrected Normalized Protein Catabolic Rate, Serum Albumin, and Mortality in Patients on Hemodialysis.
    Eriguchi R; Obi Y; Streja E; Tortorici AR; Rhee CM; Soohoo M; Kim T; Kovesdy CP; Kalantar-Zadeh K
    Clin J Am Soc Nephrol; 2017 Jul; 12(7):1109-1117. PubMed ID: 28490436
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Within-center correlation in dialysis adequacy.
    Fink JC; Gardner JF; Armistead NC; Turner MS; Light PD
    J Clin Epidemiol; 2000 Jan; 53(1):79-85. PubMed ID: 10693907
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Exploring the reverse J-shaped curve between urea reduction ratio and mortality.
    Chertow GM; Owen WF; Lazarus JM; Lew NL; Lowrie EG
    Kidney Int; 1999 Nov; 56(5):1872-8. PubMed ID: 10571796
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Longer-term outcomes of darbepoetin alfa versus epoetin alfa in patients with ESRD initiating hemodialysis: a quasi-experimental cohort study.
    Winkelmayer WC; Chang TI; Mitani AA; Wilhelm-Leen ER; Ding V; Chertow GM; Brookhart MA; Goldstein BA
    Am J Kidney Dis; 2015 Jul; 66(1):106-13. PubMed ID: 25943715
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Variation in infection prevention practices in dialysis facilities: results from the national opportunity to improve infection control in ESRD (End-Stage Renal Disease) project.
    Chenoweth CE; Hines SC; Hall KK; Saran R; Kalbfleisch JD; Spencer T; Frank KM; Carlson D; Deane J; Roys E; Scholz N; Parrotte C; Messana JM
    Infect Control Hosp Epidemiol; 2015 Jul; 36(7):802-6. PubMed ID: 25773538
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Variable mortality rates among dialysis treatment centers.
    McClellan WM; Flanders WD; Gutman RA
    Ann Intern Med; 1992 Aug; 117(4):332-6. PubMed ID: 1637029
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Forum of the End-Stage Renal Disease Networks' role in implementing the National Kidney Foundation-Dialysis Outcomes Quality Initiative Clinical Practice Guidelines.
    Diamond LH; Daly DC
    Adv Ren Replace Ther; 1999 Jan; 6(1):28-35. PubMed ID: 9925147
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Relationship among length of facility ownership, clinical performance, and mortality.
    Van Wyck D; Robertson J; Nissenson A; Provenzano R; Kogod D
    Clin J Am Soc Nephrol; 2010 Feb; 5(2):248-51. PubMed ID: 20007679
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.